Remember Ernie Tremblay’s pitch about a “tiny South Texas lab” that was about to cure every disease using its revolutionary CD19 Cancer Vaccine technology, and ignite a bidding war following its fantastical release of exciting information on June 23? Well, it’s back. Not the stock, that’s still languishing around where it was before Tremblay got […]
Articles
This Friday File article was originally released to the Irregulars on June 16, we have now opened it up for anyone to read in hopes of answering some questions that continue to roll in about the latest Biotech Insider Alert ads. The text below has not been updated or revised, though I and other readers […]
I know quite a few folks got to chatting about Bellicum (BLCM) following Ernie Tremblay’s overly heated pitch for the stock last week, covered in the Friday File a week ago… and, well, things so far are going as they often do: Overhype the ad, overpromise some dramatic results from a presentation that’s really much […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics and his words and opinions are his own. He has agreed to our trading restrictions. You can see his previous articles here. Enjoy!] In 1970, splendid French filmmaker Erich Rohmer wrote and directed a nearly perfect flick: […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see all of his past articles here. Enjoy!] Do you have quirky, enigmatic notions that hang with you? Douglas Hofstadter, writing in Godel, Escher and Bach: […]
Gumshoe BioDimSum II: Corralling the “A” Biotechs Plus a New Long Selection[Ed. Note: Dr. KSS writes for our Irregulars about medicine and biotech stocks. As always, he has agreed our trading restrictions, and his words and opinions are his own. You can find all of his previous articles here. And now, for some dim sum….] Greetings Irregulars, and welcome to Stock Gumshoe’s festive second BioDimSum shindig, a periodic round-up […]
Comments
I believe its the same pitch Travis has already wrote about, Bellicum Pharmaceuticals https://www.stockgumshoe.com/r...
A friend is someone with whom you dare to be yourself. ~ Frank Crane Immunotherapy has been the most exciting advance...
BELLICUM PHARMACEUTICALS INC COM BLCM: NASDAQ...
I'm new to Gumshoe and this thread. Just wanted to ask if anyone has knowledge of Lexagene Holdings Inc. (LXXGF) and/or...
Hey gumshoe bellicum pharmaceuticals was supposed to announce a licensing deal today either with Novartis or glaxo Smith...
See the following article at Yahoo.com Finance: Here's Why Bellicum Pharmaceuticals Fell as Much as 13.8% Today...
This is just now: BLCM Bellicum Pharmaceuticals Inc $0.20 (1.52%) $20.00 $49.05 (3.82%) MBRX Moleculin...
The BLCM goes up again today: BLCM Bellicum Pharmaceuticals Inc 100 $1,284.95 $12.85 $13.55 $0.19 (1.42%) ...
New Clinical Trial Review: Leukemia Patients Treated by Bellicum Pharmaceuticals -- 91% remission, 94% Survival (median ...
Bellicum Pharmaceuticals Inc BLCM....
Annemarie Moseley Bellicum Pharmaceuticals Inc.,Houston,United States Speaker of (S146) BPX-501 DONOR T CELL INFUSI...
John Weinberg Bellicum Pharmaceuticals Inc.,Houston,United States Speaker of (S146) BPX-501 DONOR T CELL INFUSION (...
Nov. 1, 2016-- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM) and Ospedale Pediatrico Bambino Gesù (OPBG), a leading Euro...
I've noticed some confusion about the nature of the $388,000 in this thread. The $388,000 is in relation to their 2016 f...
Maybe helpful? Maybe someone can help confirm relevance? All accepted abstracts of the 22nd Congress are now publishe...
This is a bit of an aside, but I've been thinking of putting together a tracking index of the biotechs followed here. W...
Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and deve...
Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and deve...
A take on Juno Therapeutics (JUNO) and Bellicum Pharmaceuticals (BLCM). http://www.fool.com/investing/general/2015/01/2...
RE:BLCM Bellicum Pharmaceuticals Announces Successful Dosing of First Patient Cohort With BPX-501 T Cells Following Hap...
KSS the Magical Marvelous (De)Mystifying Tour Guide: You mentioned Bellicum Pharmaceuticals ($BLCM) as, "a new immuno...
Bellicum Pharmaceuticals ($BLCM) is a new immuno-onc play with designs on T-cell mediated tumor kill by distinct approac...